Does reduced miR-485-5p expression predict poor prognosis in patients with gastric cancer?
Expression level of miR-485-5p serves as a novel biomarker for the overall survival of patients with gastric cancer.
The prevalence of coeliac disease is high in a rural Australian community. Most patients are undiagnosed, and asymptomatic.